Cargando…
Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749243/ https://www.ncbi.nlm.nih.gov/pubmed/33367219 http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006 |
_version_ | 1783625272921161728 |
---|---|
author | El Kawkgi, Omar M. Li, Dingfeng Kotwal, Anupam Wermers, Robert A. |
author_facet | El Kawkgi, Omar M. Li, Dingfeng Kotwal, Anupam Wermers, Robert A. |
author_sort | El Kawkgi, Omar M. |
collection | PubMed |
description | As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedingly rare. We report a case of hypoparathyroidism induced by immune checkpoint drugs, highlighting the need for awareness of this emerging complication. |
format | Online Article Text |
id | pubmed-7749243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77492432020-12-22 Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy El Kawkgi, Omar M. Li, Dingfeng Kotwal, Anupam Wermers, Robert A. Mayo Clin Proc Innov Qual Outcomes Case Report As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedingly rare. We report a case of hypoparathyroidism induced by immune checkpoint drugs, highlighting the need for awareness of this emerging complication. Elsevier 2020-11-03 /pmc/articles/PMC7749243/ /pubmed/33367219 http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report El Kawkgi, Omar M. Li, Dingfeng Kotwal, Anupam Wermers, Robert A. Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy |
title | Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy |
title_full | Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy |
title_fullStr | Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy |
title_full_unstemmed | Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy |
title_short | Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy |
title_sort | hypoparathyroidism: an uncommon complication associated with immune checkpoint inhibitor therapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749243/ https://www.ncbi.nlm.nih.gov/pubmed/33367219 http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006 |
work_keys_str_mv | AT elkawkgiomarm hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy AT lidingfeng hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy AT kotwalanupam hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy AT wermersroberta hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy |